Marcel Bally

University of British Columbia, Vancouver, Vancouver, BC, Canada 
Pharmaceutical Chemistry, Immunology, Cell Biology
"Marcel Bally"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bortnik S, Choutka C, Horlings HM, et al. (2016) Identification of breast cancer cell subtypes sensitive to ATG4B inhibition. Oncotarget
Waterhouse DN, Sutherland BW, Santos ND, et al. (2014) Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities. Investigational New Drugs. 32: 1071-82
Dragowska WH, Weppler SA, Wang JC, et al. (2013) Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer. Plos One. 8: e76503
Hare JI, Neijzen RW, Anantha M, et al. (2013) Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil. Plos One. 8: e62349
Verreault M, Weppler SA, Stegeman A, et al. (2013) Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model. Plos One. 8: e59597
Ho EA, Osooly M, Strutt D, et al. (2013) Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model. Journal of Pharmaceutical Sciences. 102: 227-36
Waterhouse DN, Yapp D, Verreault M, et al. (2011) Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy. Nanomedicine (London, England). 6: 1645-54
Dragowska WH, Weppler SA, Qadir MA, et al. (2011) The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity. Bmc Cancer. 11: 420
Verreault M, Strutt D, Masin D, et al. (2011) Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine. Bmc Cancer. 11: 124
Kalra J, Anantha M, Warburton C, et al. (2011) Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267. Cancer Biology & Therapy. 11: 826-38
See more...